Authors:
ELLIOT BC
WISNEWSKI AV
JOHNSON J
FENWICKSMITH D
WIEST P
HAMER D
RESINA T
FLANIGAN TP
Citation: Bc. Elliot et al., IN-VITRO INHIBITION OF CRYPTOSPORIDIUM-PARVUM INFECTION BY HUMAN MONOCLONAL-ANTIBODIES, Infection and immunity, 65(9), 1997, pp. 3933-3935
Authors:
BISSONNETTE M
JOHNSON J
WEXLER S
SKAROSI S
WALI R
Citation: M. Bissonnette et al., URSODEOXYCHOLATE, A CHEMOPREVENTIVE BILE-SALT IN COLONIC CARCINOGENESIS, STIMULATES APOPTOSIS AND INHIBITS BCL-2 EXPRESSION IN CACO-2 CELLS, Gastroenterology, 112(4), 1997, pp. 539-539
Citation: J. Johnson, EPA READIES STUDY OF FUTURE COSTS, BENEFITS OF IMPLEMENTING 1990 CLEAN-AIR ACT, Environmental science & technology, 31(1), 1997, pp. 16-17
Authors:
SCHWANDER SK
DIETRICH M
MUGYENYI P
KITYO C
OKWERA A
JOHNSON J
NSUBUGA P
RUESCHGERDES S
WHALEN C
Citation: Sk. Schwander et al., CLINICAL COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED PULMONARY TUBERCULOSIS DURING SHORT-COURSE ANTITUBERCULOSIS THERAPY, East African medical journal, 74(9), 1997, pp. 543-548
Authors:
LEVINE JH
APPLEGATE WB
ALAGONA P
ANGELO J
HERKENDER C
FOWLER N
BENZ JR
BOYDEN T
PAMATER R
CUTLER N
DEQUATTRO V
LU ZW
DOHERTY JE
BRANDT D
FELICETTA JV
JOHNSON J
LEFOR N
HAYDEN CT
GLASSER S
HAWKINS C
GOLDSTEIN R
CARLSON K
COOPER W
GRAY JM
HORWITZ L
CLEGG L
IVANHOE RJ
WALKER P
JAIN A
MCMAHON G
VARGAS R
GOTZKOWSKY S
KAIHLANEN M
RUFF D
ZUNKER R
MCGUIRE R
MASSIE B
AMMON S
MILLER W
LUCKASEN G
NEWMAN BG
NOBLE R
PASTER R
COULTHARD D
GEHIN B
PLESKOW W
PETERSON J
PUNZI H
RIESS J
WALKER K
RAM CVS
REEVES R
HALL J
INOUE S
JACQUES P
SAVRAN S
HESS T
COWAN B
SERFER HM
SHAW D
SILBERMAN H
ROSEN J
SCHAFFHAUSEN L
MILANES M
SINGH B
RABANAL P
SNYDER F
SOLER J
STEIN W
OSHRAIN C
BUDD J
ABBOTT R
STRAUSS M
ALSTADT K
CARTER P
WEBER M
WEIR M
MUELLER C
WOLFSON PO
DUNLAP S
WIPPLE D
BOHLNER N
WOOD B
MCGURREN N
Citation: Jh. Levine et al., TRANDOLAPRIL AND VERAPAMIL SLOW-RELEASE IN THE TREATMENT OF HYPERTENSION - A DOSE-RESPONSE ASSESSMENT WITH THE USE OF A MULTIFACTORIAL TRIAL DESIGN, Current therapeutic research, 58(6), 1997, pp. 361-374
Citation: C. Ballow et al., PHARMACOKINETICS OF A NEW 5-PERCENT FORMULATION OF HEPATITIS-B IMMUNEGLOBULIN (H-BIG(R)), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 60-60
Authors:
KOFOED KF
CZERNIN J
JOHNSON J
KOBASHIGAWA J
PHELPS ME
LAKS H
SCHELBERT HR
Citation: Kf. Kofoed et al., EFFECTS OF CARDIAC ALLOGRAFT VASCULOPATHY ON MYOCARDIAL BLOOD-FLOW, VASODILATORY CAPACITY, AND CORONARY VASOMOTION, Circulation, 95(3), 1997, pp. 600-606